Price

rebased to 0%

ABT, solidABBV, dashed

ABTAbbott Laboratories

110.28· pre 109.95· delayed

Mkt cap$183.8BRevenue$12.6BQ2 FY26Revenue$44.3BFY25

ABBVAbbVie Inc.

288.78· pre 286.87· delayed

Pre-marketNov 3 '26delayed

Mkt cap$521.1BRevenue$17.0BQ2 FY26Revenue$61.2BFY25

vs

Compare

Pre-marketNov 3 '26delayed

ABTAbbott Laboratories

vs

ABBVAbbVie Inc.

110.28pre 109.95delayed

Price

288.78pre 286.87delayed

$183.8B

Mkt cap

$521.1B

Q2 FY26$12.6B

Revenue

$17.0BQ2 FY26

FY25$44.3B

Revenue

$61.2BFY25

ABT compared with ABBV: revenue, margins and what each company keeps, and the suppliers and customers both name